Evans J, Maccabee M, Hatahet Z, Courcelle J, Bockrath R, Ide H, Wallace S
University of Vermont, Department of Microbiology and Molecular Genetics, Markey Center for Molecular Genetics, Burlington 05405.
Mutat Res. 1993 May;299(3-4):147-56. doi: 10.1016/0165-1218(93)90092-r.
We have used thymine glycol and dihydrothymine as representative ring saturation products resulting from free-radical interaction with DNA pyrimidines, and urea glycosides and beta-ureidoisobutyric acid (UBA) as models for pyrimidine-ring fragmentation products. We have shown that thymine glycol and the ring-fragmentation products urea and beta-ureidoisobutyric acid, as well as abasic sites, are strong blocks to DNA polymerases in vitro. In contrast, dihydrothymine is not a block to any of the polymerases tested. For thymine glycol, termination sites were observed opposite the putative lesions, whereas for the ring-fragmentation products, the termination sites were primarily one base prior to the lesion. These and other data have suggested that thymine glycol codes for an A, and that a base is stably inserted opposite the damage, whereas when a base is inserted opposite the non-coding lesions, it is removed by the 3-->5 exonuclease activity of DNA polymerase I. Despite their efficiency as blocking lesions, thymine glycol, urea and UBA can be bypassed at low frequency in certain specific sequence contexts. When the model lesions were introduced individually into single-stranded biologically active DNA, we found that thymine glycol, urea, beta-ureidoisobutyric acid, and abasic sites were all lethal lesions having an activation efficiency of 1, whereas dihydrothymine was not. Thus the in vitro studies predicted the in vivo results. When the survival of biologically active single-stranded DNA was examined in UV-induced Escherichia coli cells where the block to replication was released, no increase in survival was observed for DNA containing urea or abasic sites, suggesting inefficient bypass of these lesions. In contrast, beta-ureidoisobutyric acid survival was slightly enhanced, and transfecting DNA containing thymine glycols was significantly reactivated. When mutation induction by unique lesions was measured using f1-K12 hybrid DNA containing an E. coli target gene, thymine glycols and dihydrothymine were found to be inefficient as premutagenic lesions, suggesting that in vivo, as in vitro, they primarily code for A. In contrast, urea and beta-ureidoisobutyric acid were efficient premutagenic lesions, with beta-ureidoisobutyric acid being about 4-5-fold more effective than urea glycosides, which have approximately the same rate of mutation induction as abasic sites from purines. Sequence analysis of the mutations resulting from these ring-fragmentation products shows that the mutations produced are both lesion and sequence context dependent. The possible roles that bypass efficiency and lesion-directed misinsertion might play in mutagenesis are discussed.
我们使用胸腺嘧啶乙二醇和二氢胸腺嘧啶作为自由基与DNA嘧啶相互作用产生的代表性环饱和产物,使用脲糖苷和β-脲基异丁酸(UBA)作为嘧啶环断裂产物的模型。我们已经表明,胸腺嘧啶乙二醇、环断裂产物尿素和β-脲基异丁酸以及无碱基位点在体外是DNA聚合酶的强阻断剂。相比之下,二氢胸腺嘧啶对所测试的任何聚合酶都不是阻断剂。对于胸腺嘧啶乙二醇,在假定的损伤位点对面观察到终止位点,而对于环断裂产物,终止位点主要在损伤位点之前一个碱基处。这些以及其他数据表明,胸腺嘧啶乙二醇编码一个A,并且在损伤位点对面稳定地插入一个碱基,而当在非编码损伤位点对面插入一个碱基时,它会被DNA聚合酶I的3→5外切核酸酶活性去除。尽管胸腺嘧啶乙二醇、尿素和UBA作为阻断损伤有效,但在某些特定序列背景下它们可以以低频率被绕过。当将模型损伤单独引入单链生物活性DNA时,我们发现胸腺嘧啶乙二醇、尿素、β-脲基异丁酸和无碱基位点都是致死性损伤,激活效率为1,而二氢胸腺嘧啶不是。因此,体外研究预测了体内结果。当在紫外线诱导的大肠杆菌细胞中检查生物活性单链DNA的存活率时,其中复制阻断被解除,含有尿素或无碱基位点的DNA的存活率没有增加,表明这些损伤的绕过效率低下。相比之下,β-脲基异丁酸的存活率略有提高,转染含有胸腺嘧啶乙二醇的DNA被显著重新激活。当使用含有大肠杆菌靶基因的f1-K12杂合DNA测量独特损伤诱导的突变时,发现胸腺嘧啶乙二醇和二氢胸腺嘧啶作为前诱变损伤效率低下,表明在体内,与体外一样,它们主要编码A。相比之下,尿素和β-脲基异丁酸是有效的前诱变损伤,β-脲基异丁酸的效果比脲糖苷大约高4-5倍,脲糖苷的突变诱导率与嘌呤产生的无碱基位点大致相同。对这些环断裂产物产生的突变进行序列分析表明,产生的突变既依赖于损伤也依赖于序列背景。讨论了绕过效率和损伤导向的错误插入在诱变中可能发挥的作用。